Journal
Journal issues Editorial Advisory Board Aims & Scope
Spotlights
Webinars
Channels
- Tools and Technologies
Fast Facts
Media Kit
Media kit Editorial Calendar
About
Get in touch Meet the Team
Other journals

Update your profile Logout

COMBINATION THERAPY DEVELOPMENT: EMERGING I-O THERAPEUTIC MODALITIES AND PREDICTIVE TECHNOLOGIES

Customizing T cell biology: armoring approaches to optimize allogeneic CAR-T therapies

Immuno-Oncology Insights 2022; 3(10), 449–452

DOI: 10.18609/ioi.2022.048

Published: 28 November 2022

Viewpoint

Jakob Dupont

“Within the past couple of decades, significant progress has been made in the landscape of immunotherapy, altering how certain cancers are treated.”

Please enter your email to access content

Welcome back to Bioinsights, please log in to access this content

Email address

Password

Forgotten password?

Please note all fields marked with an * are mandatory

Title*

First name*

Last name*

Email*

Password*

Country*

Job Title*

Please select which journals you are interested in:

Cell and Gene Therapy Insights
Immuno-Oncology Insights
Vaccine Insights

Please select your areas of interest:

Drug Delivery
Public Health
Bioanalytics
Manufacturing
Vectors
Analytical/QA/QC/CMC
Business Development/Licensing/Finance
Regulatory
Supply Chain
Clinical Trials
Preclinical R&D
Discovery
Patents & IP
Market Access/Pricing

I would like to receive a weekly email newsletter and updates from BioInsights, subject to their Privacy Policy

If you have any problem accessing our content, please email info@insights.bio

Terms & Conditions
Privacy Policy